Physician
Tilki, Natalia
Tilki, Natalia was paid $878K by Medicaid between Jan 2018 and Dec 2024, across 21 billing codes. Its largest line is 68761, — 24% of everything it billed.
33Billing provider infoTILKI, NATALIA
ENCINO, CA 91436
ENCINO, CA 91436
33aNPI1790793248assigned 08/03/2006
33bProvider typeOphthalmology Physician
28Total paid$878K
24GClaims25,378
24DCodes billed21
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ophthalmology Physician providers in California
Rank by total paid#89 of 759
Median peer was paid$35K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,817 | $63K | |
| 2019 | 3,546 | $130K | |
| 2020 | 2,384 | $96K | |
| 2021 | 2,340 | $83K | |
| 2022 | 3,690 | $141K | |
| 2023 | 4,839 | $171K | |
| 2024incomplete | 5,762 | $194K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 68761 | 24% | 2,806 | 1,070 | $212K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 18% | 5,117 | 4,479 | $160K |
| 67028 | Intravitreal injection of a pharmacologic agent | 9.2% | 372 | 291 | $81K |
| 92250 | 7.5% | 2,349 | 2,261 | $66K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 7.3% | 1,727 | 1,590 | $64K |
| 92134 | 6.1% | 2,074 | 1,948 | $53K | |
| 92082 | 4.9% | 1,754 | 1,738 | $43K | |
| 92133 | 4.9% | 1,807 | 1,792 | $43K | |
| 92100 | 4.6% | 1,882 | 1,848 | $40K | |
| 92226 | 4.4% | 1,525 | 690 | $39K | |
| 92020 | 2.7% | 1,796 | 1,781 | $24K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.8% | 303 | 302 | $16K |
9 more codes
| J9035 | Injection, bevacizumab, 10 mg | 1.7% | 371 | $15K |
| 92202 | 1.4% | 1,046 | $12K | |
| 99205 | Prolong outpt/office vis | <1% | 68 | $5K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 89 | $2K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 77 | $2K |
| 92015 | Determination of refractive state | <1% | 130 | $934.55 |
| V2020 | Frames, purchases | <1% | 39 | $480.30 |
| 76514 | <1% | 31 | $320.89 | |
| 92285 | <1% | 15 | $124.83 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.